Trial intelligence / Profile preview

Ilaprazole vs Lansoprazole in Erosive Esophagitis

NCT00471094Phase 2Completed

Sponsor
Takeda
Start
May 2007
Primary completion
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of ilaprazole in erosive esophagitis (EE), sponsored by Takeda. Started May 2007; status: completed.

02

Drugs

ilaprazole
03

Conditions

erosive esophagitis (EE)

Beyond the preview

Go deeper on NCT00471094.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00471094.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call